Insider · CIK 0001281719

ODINK DEBRA

Reports to the SEC for 1 company · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001281719

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-10-12	Anthera Pharmaceuticals IncS Sale	Chief Technology Officer	SSale	−1,205 sh	$6.15	−$7,410.75	7,896
2015-09-17	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Technology Officer	AAward	+60K sh	—	—	60,000
2015-09-17	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Technology Officer	AAward	+30K sh	—	—	30,000
2014-12-30	Anthera Pharmaceuticals IncG Gift	Chief Technology Officer	GGift	−1,364 sh	—	—	9,101
2014-12-30	Anthera Pharmaceuticals IncG Gift	Chief Technology Officer	GGift	+1,364 sh	—	—	13,855
2014-12-30	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Technology Officer	AAward	+120K sh	—	—	120,000
2014-03-25	Anthera Pharmaceuticals IncF Tax Payment	Chief Technology Officer	FTax Payment	−2,783 sh	$3.30	−$9,183.9	6,601
2014-03-25	Anthera Pharmaceuticals IncA Award	Chief Technology Officer	AAward	−3,864 sh	—	—	10,465
2014-03-25	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Technology Officer	AAward	+10.1K sh	—	—	10,070
2013-06-30	Anthera Pharmaceuticals IncF Tax Payment	Chief Technology Officer	FTax Payment	−2,248 sh	$0.49	−$1,101.52	75,074
2013-05-17	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Technology Officer	AAward	+1.4M sh	—	—	1,400,000
2013-03-25	Anthera Pharmaceuticals IncA Award	Chief Technology Officer	AAward	+49.5K sh	—	—	77,322
2013-01-10	Anthera Pharmaceuticals IncG Gift	Chief Technology Officer	GGift	−4,009 sh	—	—	27,803
2013-01-10	Anthera Pharmaceuticals IncG Gift	Chief Technology Officer	GGift	+4,009 sh	—	—	99,937
2013-01-03	Anthera Pharmaceuticals IncF Tax Payment	Chief Technology Officer	FTax Payment	−3,409 sh	$0.69	−$2,352.21	31,812
2012-06-30	Anthera Pharmaceuticals IncF Tax Payment	Chief Technology Officer	FTax Payment	−1,838 sh	$0.69	−$1,268.22	24,821
2012-03-30	Anthera Pharmaceuticals IncStock Option (right to buy)A Award	Chief Technology Officer	AAward	+160K sh	—	—	160,000
2012-03-01	Anthera Pharmaceuticals IncS Sale	Chief Technology Officer	SSale	−2,000 sh	$6.57	−$13.1K	26,659
2012-02-06	Anthera Pharmaceuticals IncA Award	Chief Technology Officer	AAward	+7,418 sh	—	—	28,659
2012-02-01	Anthera Pharmaceuticals IncS Sale	Chief Technology Officer	SSale	−2,000 sh	$7.67	−$15.3K	21,241
2012-01-10	Anthera Pharmaceuticals IncS Sale	Chief Technology Officer	SSale	−800 sh	$6.51	−$5,205.28	23,241
2012-01-06	Anthera Pharmaceuticals IncS Sale	Chief Technology Officer	SSale	−1,200 sh	$6.50	−$7,800	24,441
2011-06-30	Anthera Pharmaceuticals IncF Tax Payment	Chief Technology Officer	FTax Payment	−3,670 sh	$8.17	−$30K	25,641
2011-04-13	Anthera Pharmaceuticals IncM Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	+3,311 sh	$1.51	+$4,999.61	29,311
2011-04-13	Anthera Pharmaceuticals IncStock Option (right to buy)M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	−3,311 sh	—	—	25,894
2010-12-31	Anthera Pharmaceuticals IncStock Option (right to buy)A Award	Chief Technology Officer	AAward	+95K sh	—	—	95,000
2010-09-24	Anthera Pharmaceuticals IncP Purchase	Chief Technology Officer	PPurchase	+1,000 sh	$4.20	+$4,200	26,000
2010-06-30	Anthera Pharmaceuticals IncA Award	Chief Technology Officer	AAward	+5,000 sh	—	—	5,000
2010-06-30	Anthera Pharmaceuticals IncA Award	Chief Technology Officer	AAward	+20K sh	—	—	25,000
2010-03-04	Anthera Pharmaceuticals IncC Conversion	Chief Technology Officer	CConversion	+17.5K sh	—	—	95,928
2010-03-04	Anthera Pharmaceuticals IncSeries A-1 Convertible Preferred StockC Conversion	Chief Technology Officer	CConversion	−17.5K sh	—	—	0

Recent filings

Accepted (ET)
Oct 134
Anthera Pharmaceuticals Inc0001214659-15-007104
SEC(opens sec.gov)
Sep 184
Anthera Pharmaceuticals Inc0001214659-15-006720
SEC(opens sec.gov)
Jan 24
Anthera Pharmaceuticals Inc0001214659-15-000048
SEC(opens sec.gov)
Mar 274
Anthera Pharmaceuticals Inc0001214659-14-002287
SEC(opens sec.gov)
Jul 24
Anthera Pharmaceuticals Inc0001214659-13-003732
SEC(opens sec.gov)
May 214
ODINK DEBRA0001214659-13-002947
SEC(opens sec.gov)
Mar 274
ODINK DEBRA0001214659-13-001689
SEC(opens sec.gov)
Jan 114
ODINK DEBRA0001214659-13-000154
SEC(opens sec.gov)
Jan 74
ODINK DEBRA0001214659-13-000082
SEC(opens sec.gov)
Jul 34
ODINK DEBRA0001104659-12-047526
SEC(opens sec.gov)
Apr 34
ODINK DEBRA0001104659-12-023615
SEC(opens sec.gov)
Mar 54
ODINK DEBRA0001104659-12-015654
SEC(opens sec.gov)
Feb 64
ODINK DEBRA0001104659-12-007054
SEC(opens sec.gov)
Feb 34
ODINK DEBRA0001104659-12-006559
SEC(opens sec.gov)

Companies

Anthera Pharmaceuticals IncChief Technology Officer

Address

C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B

HAYWARD, CA, 94545